Loading institutional data...
Loading institutional data...
Held by 278 of 5,944 reporting institutions (94th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $54.25 today, the market must believe free cash flow compounds -0.2%/yr for a decade (off $154M normalized FCF).
The market's -0.2% is more conservative than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt -$961M
mean 81.3% · volatility σ 150% · implied rate exceeded in 6/9 yrs
Central path = implied -0.2%/yr growth; shaded band = ±1σ (150%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
7/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $42M buybacks = $42M returned on $137M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.01B 100.0% | $939.8M 100.0% | $881.7M 100.0% | $842.6M 100.0% | $749.0M 100.0% | $618.0M 100.0% | $502.4M 100.0% | $420.5M 100.0% | $338.9M 100.0% | $261.1M 100.0% |
| Cost of Revenue | $342.3M 33.9% | $326.1M 34.7% | $325.2M 36.9% | $342.6M 40.7% | $305.9M 40.8% | $227.4M 36.8% | $183.6M 36.5% | $145.7M 34.7% | $116.2M 34.3% | $99.4M 38.1% |
| Cost of Products | — | — | — | — | — | — | — | — | $80.6M 23.8% | $69.2M 26.5% |
| Research & Development | $270.2M 26.7% | $255.9M 27.2% | $245.1M 27.8% | $218.6M 25.9% | $177.7M 23.7% | $152.1M 24.6% | $114.4M 22.8% | $89.2M 21.2% | $72.8M 21.5% | $44.3M 17.0% |
| Selling, General & Admin | $110.4M 10.9% | $108.9M 11.6% | $112.9M 12.8% | $106.7M 12.7% | $87.4M 11.7% | $78.6M 12.7% | $70.0M 13.9% | $95.8M 22.8% | $55.4M 16.3% | $57.9M 22.2% |
| Total Operating Expenses | $535.3M 52.9% | $505.1M 53.7% | $489.7M 55.5% | $448.9M 53.3% | $381.5M 50.9% | $334.3M 54.1% | $268.4M 53.4% | $262.6M 62.4% | $189.4M 55.9% | $147.7M 56.6% |
| Operating Income | $133.6M 13.2% | $108.5M 11.5% | $66.8M 7.6% | $51.0M 6.1% | $61.6M 8.2% | $56.3M 9.1% | $50.4M 10.0% | $12.2M 2.9% | $33.4M 9.8% | $14.1M 5.4% |
| Interest Expense | $17.3M 1.7% | $11.4M 1.2% | $3.4M 0.4% | $3.1M 0.4% | — | — | — | — | — | — |
| Interest & Investment Income | $45.6M 4.5% | $47.4M 5.0% | $29.8M 3.4% | $8.8M 1.0% | $587K 0.1% | $870K 0.1% | $4.9M 1.0% | $2.3M 0.5% | $1.0M 0.3% | — |
| Other Income (Expense), net | $4.6M 0.5% | -$2.8M -0.3% | $4.6M 0.5% | -$59K -0.0% | -$134K -0.0% | $25.6M 4.1% | $6.5M 1.3% | $143K 0.0% | $35K 0.0% | $513K 0.2% |
| Pretax Income | $166.6M 16.5% | $141.8M 15.1% | $97.8M 11.1% | $56.6M 6.7% | $46.1M 6.2% | $80.2M 13.0% | $58.9M 11.7% | $11.7M 2.8% | $32.2M 9.5% | $14.4M 5.5% |
| Income Tax Expense | $37.6M 3.7% | $19.3M 2.1% | $17.5M 2.0% | $962K 0.1% | -$5.1M -0.7% | $3.5M 0.6% | $5.6M 1.1% | -$9.8M -2.3% | $3.0M 0.9% | $4.2M 1.6% |
| Net Income | $131.6M 13.0% | $122.5M 13.0% | $80.3M 9.1% | $55.6M 6.6% | $51.2M 6.8% | $76.7M 12.4% | $53.5M 10.7% | $21.5M 5.1% | $29.3M 8.6% | $10.2M 3.9% |
| Per Share | ||||||||||
| EPS (Basic) | $2.66 | $2.50 | $1.63 | $1.13 | $1.05 | $1.59 | $1.11 | $0.45 | $0.63 | $0.22 |
| EPS (Diluted) | $2.46 | $2.29 | $1.53 | $1.07 | $1.01 | $1.53 | $1.06 | $0.43 | $0.59 | $0.21 |
| Weighted Avg Shares (Basic) | 49.8M | 49.6M | 49.8M | 49.9M | 49.9M | 49.0M | 48.4M | 47.6M | 46.7M | 45.7M |
| Weighted Avg Shares (Diluted) | 58.9M | 58.0M | 54.6M | 54.9M | 51.9M | 51.0M | 50.3M | 49.7M | 49.2M | 47.9M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 11-yr range · 9th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 11-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 3.0× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 34.7 | 36.5 | 36.8 | 40.8 | 40.7 | 36.9 | 34.7 | 33.9 |
| R&D | 21.2 | 22.8 | 24.6 | 23.7 | 25.9 | 27.8 | 27.2 | 26.7 |
| SG&A | 22.8 | 13.9 | 12.7 | 11.7 | 12.7 | 12.8 | 11.6 | 10.9 |
| Operating Income | 2.9 | 10.0 | 9.1 | 8.2 | 6.1 | 7.6 | 11.5 | 13.2 |
| Income Tax | -2.3 | 1.1 | 0.6 | -0.7 | 0.1 | 2.0 | 2.1 | 3.7 |
| Net Income | 5.1 | 10.7 | 12.4 | 6.8 | 6.6 | 9.1 | 13.0 | 13.0 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on ALRM: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 743 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSM | $10.83T | — | — | — | — | — | — | — | — | — | 3,121 |
| NVDA | $5.20T | 43.6× | 39.0× | 24.1× | 65.5% | 71.1% | 55.6% | 76.3% | 72.4% | 0.1× | 5,582 |
| AAPL | $4.91T | 44.6× | 34.3× | 11.8× | 6.4% | 46.9% | 26.9% | 152% | 68.1% | 0.6× | 5,858 |
| MSFT | $3.64T | 27.3× | 19.3× | 11.0× | 17.8% | 67.9% | 40.3% | 30.2% | 27.7% | 0.2× | 5,944 |
| AVGO | $1.61T | 71.2× | 63.6× | 25.2× | 23.9% | 67.8% | 36.2% | 28.4% | 15.8% | 2.5× | 4,442 |
| MU | $1.04T | 122.1× | 57.5× | 27.8× | 48.9% | 39.8% | 22.8% | 15.8% | 12.9% | 0.7× | 2,894 |
| AMD | $835.4B | 193.4× | 197.6× | 24.1× | 34.3% | 49.5% | 12.5% | 6.9% | 6.5% | 0.8× | 3,059 |
| INTC | $504.6B | — | 62.9× | 9.6× | -0.5% | 34.8% | -0.5% | -0.2% | -0.2% | 5.5× | 2,495 |
| CSCO | $426.7B | 42.3× | 35.8× | 7.5× | 5.3% | 64.9% | 18.0% | 21.7% | 13.6% | 2.3× | 3,560 |
| PLTR | $416.9B | 276.7× | 288.5× | 93.2× | 56.2% | 82.4% | 36.3% | 22.0% | 22.0% | — | 2,883 |
| DELL | $367.3B | 64.9× | 34.6× | 3.2× | 18.8% | 20.0% | 5.2% | -240% | 20.4% | 2.8× | 1,564 |
| LRCX | $341.6B | 64.9× | 54.5× | 18.5× | 23.7% | 48.7% | 29.1% | 54.3% | 37.4% | 0.7× | 2,500 |
| AMAT | $329.4B | 48.0× | 37.9× | 11.6× | 4.4% | 48.7% | 24.7% | 34.3% | 25.9% | 0.8× | 2,826 |
| RPAY | $325.1B | — | — | 1051.3× | -1.2% | 75.0% | -83.0% | -53.0% | -28.2% | -1.7× | 142 |
| UMC | $283.0B | — | — | — | — | — | — | — | — | — | 302 |
| SAP | $261.9B | — | — | — | — | — | — | — | — | — | 794 |
| ARM | $259.6B | 287.0× | 223.6× | 52.8× | 22.8% | 97.5% | 18.4% | 10.9% | 10.9% | — | 730 |
| PANW | $250.9B | 234.8× | 156.8× | 27.2× | 14.9% | 73.4% | 12.3% | 14.5% | 14.5% | — | 2,374 |
| ANET | $248.2B | 71.8× | 62.7× | 27.6× | 28.6% | 64.1% | 39.0% | 28.4% | 28.4% | — | 1,930 |
| TXN | $236.9B | 47.8× | 31.2× | 13.4× | 13.0% | 57.0% | 28.3% | 30.7% | 16.5% | 1.8× | 2,345 |
| CRM | $232.8B | 32.1× | 25.2× | 5.6× | 9.6% | 77.7% | 18.0% | 12.6% | 10.1% | 1.5× | 2,547 |
| IBM | $222.5B | 21.3× | — | 3.3× | 7.6% | 58.2% | 15.7% | 32.4% | 11.3% | — | 3,351 |
| SNDK | $221.9B | — | — | 30.2× | 10.4% | 30.1% | -22.3% | -17.8% | -14.8% | -1.5× | 1,127 |
| QCOM | $198.5B | 36.9× | 14.9× | 4.5× | 13.7% | 55.4% | 12.5% | 26.1% | 15.4% | 1.1× | 2,611 |
| MRVL | $194.6B | 74.8× | 127.2× | 23.8× | 42.1% | 51.0% | 32.6% | 18.7% | 14.2% | 2.9× | 1,477 |
| ALRM | $2.8B | 22.6× | 12.4× | 2.7× | 7.6% | 66.1% | 13.0% | 15.5% | 15.5% | — | 278 |
Peers = companies sharing ALRM's sector (Technology) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.